Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co., Ltd. (OPHLY) Revenue
Annual & quarterly revenue history · segment & region breakdown
OPHLY · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsOno Pharmaceutical Co., Ltd. trailing twelve-month (TTM) revenue is $523B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Drug Manufacturers - GeneralCompare OPHLY revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Ono Pharmaceutical Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Ono Pharmaceutical Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Ono Pharmaceutical Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
OPHLY revenue · 4 questionsOPHLY's trailing twelve-month (TTM) revenue is $523B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Ono Pharmaceutical Co., Ltd. SEC filings · GAAP · Ono Pharmaceutical Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026